Interpretation of chloroquine pharmacokinetic data
暂无分享,去创建一个
R. Day | D. Cutler | S. Tett | A. McLachlan
[1] P. Geusens,et al. Chloroquine levels in blood during chronic treatment of patients with rheumatoid arthritis , 1992, European Journal of Clinical Pharmacology.
[2] D. Cutler,et al. Apparent dose-dependence of chloroquine pharmacokinetics due to limited assay sensitivity and short sampling times , 2004, European Journal of Clinical Pharmacology.
[3] Y. Bergqvist,et al. The single dose kinetics of chloroquine and its major metabolite desethylchloroquine in healthy subjects , 2004, European Journal of Clinical Pharmacology.
[4] R. Day,et al. Bioavailability of hydroxychloroquine tablets assessed with deconvolution techniques. , 1992, Journal of pharmaceutical sciences.
[5] R. Day,et al. Bioavailability of hydroxychloroquine tablets in healthy volunteers. , 1989, British journal of clinical pharmacology.
[6] R. Day,et al. A dose-ranging study of the pharmacokinetics of hydroxy-chloroquine following intravenous administration to healthy volunteers. , 1988, British journal of clinical pharmacology.
[7] J. McElnay,et al. Investigation of chloroquine binding to plastic materials , 1986 .
[8] Ö. Ericsson,et al. Enantioselective Analysis of Chloroquine and Desethylchloroquine after Oral Administration of Racemic Chloroquine , 1986, Therapeutic drug monitoring.
[9] B. Beermann,et al. Disposition of chloroquine in man after single intravenous and oral doses. , 1983, British journal of clinical pharmacology.
[10] J. Jensen,et al. Characteristics of chloroquine binding to glass and plastic. , 1983, The American journal of tropical medicine and hygiene.